Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth

American Journal of Pathology

Volumn 177, Issue 1, 2010, Pages 387-403

  Soikkeli, Johanna ^a   Podlasz, Piotr ^a,b   Yin, Miao ^a   Nummela, Pirjo ^a   Jahkola, Tiina ^c   Virolainen, Susanna ^a   Krogerus, Leena ^a   Heikkilä, Päivi ^a   Von Smitten, Karl ^c   Saksela, Olli ^c   Hölttä, Erkki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; SCLEROPROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; VERSICAN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA SEQUENCE; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MELANOCYTE; MELANOMA; MELANOMA CELL; MICROMETASTASIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR VOLUME; UPREGULATION;

EID: 77954565543     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090748     Document Type: Article

References (68)

1. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572 (Pubitemid 37328923)
2. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12:895-904 (Pubitemid 44175140)
3. Gupta GP, Massague J: Cancer metastasis: building a framework. Cell 2006, 127:679-695
4. Psaila B, Kaplan RN, Port ER, Lyden D: Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche. Breast Dis 2006, 26:65-74
5. Hirakawa S: From tumor lymphangiogenesis to lymphvascular niche. Cancer Sci 2009, 100:983-989
6. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-458
7. Ma L, Weinberg RA: Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 2008, 24:448-456
8. Pantel K, Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4:448-456
9. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648
10. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C: The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003, 10:575-581
11. Ranieri JM, Wagner JD, Azuaje R, Davidson D, Wenck S, Fyffe J, Coleman JJ,3rd: Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 2002, 9:975-981 (Pubitemid 35424631)
12. Soikkeli J, Lukk M, Nummela P, Virolainen S, Jahkola T, Katainen R, Harju L, Ukkonen E, Saksela O, Holtta E: Systematic search for the best gene expression markers for melanoma micrometastasis detection. J Pathol 2007, 213:180-189 (Pubitemid 47612240)
13. th Edition. New Jersey, John Wiley & Sons, 2002, pp. 1-239
14. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193 (Pubitemid 36181903)
15. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA: 2001, 98:5116-5121
16. Shi L, Jones WD, Jensen RV, Harris SC, Perkins RG, Goodsaid FM, Guo L, Croner LJ, Boysen C, Fang H, Qian F, Amur S, Bao W, Barbacioru CC, Bertholet V, Cao XM, Chu TM, Collins PJ, Fan XH, Frueh FW, Fuscoe JC, Guo X, Han J, Herman D, Hong H, Kawasaki ES, Li QZ, Luo Y, Ma Y, Mei N, Peterson RL, Puri RK, Shippy R, Su Z, Sun YA, Sun H, Thorn B, Turpaz Y, Wang C, Wang SJ, Warrington JA, Willey JC, Wu J, Xie Q, Zhang L, Zhang L, Zhong S, Wolfinger RD, Tong W: The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics 2008, 9 Suppl 9:S10
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550
18. Alanko T, Rosenberg M, Saksela O: FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes. J Invest Dermatol 1999, 113:111-116 (Pubitemid 29328168)
19. Ravanko K, Jarvinen K, Helin J, Kalkkinen N, Holtta E: Cysteine cathepsins are central contributors of invasion by cultured adenosyl-methionine decarboxylase-transformed rodent fibroblasts. Cancer Res 2004, 64:8831-8838 (Pubitemid 39665486)
20. Rittling SR, Chambers AF: Role of osteopontin in tumour progression. Br J Cancer 2004, 90:1877-1881
21. McAllister SS, Gifford AM, Greiner AL, Kelleher SP, Saelzler MP, Ince TA, Reinhardt F, Harris LN, Hylander BL, Repasky EA, Weinberg RA: Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 2008, 133:994-1005
22. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y: Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005, 11:7234-7242
23. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008, 1:13
24. Silva J, Smith A: Capturing pluripotency. Cell 2008, 132:532-536
25. Zabierowski SE, Herlyn M: Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 2008, 26:2890-2894
26. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massague J: TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008, 133:66-77
27. Zhou Y, Dai DL, Martinka M, Su M, Zhang Y, Campos EI, Dorocicz I, Tang L, Huntsman D, Nelson C, Ho V, Li G: Osteopontin expression correlates with melanoma invasion. J Invest Dermatol 2005, 124:1044-1052
28. Verrecchia F, Chu ML, Mauviel A: Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001, 276:17058-17062 (Pubitemid 37411506)
29. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A: Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999, 14:1239-1249
30. Ignotz RA, Endo T, Massague J: Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 1987, 262:6443-6446
31. Hocevar BA, Brown TL, Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent Smad4-independent pathway. EMBO J 1999, 18:1345-1356
32. Aguirre-Ghiso JA: Models, mechanisms, and clinical evidence for cancer dormancy. Nat Rev Cancer 2007, 7:834-846 (Pubitemid 350006258)
33. Nguyen DX, Bos PD, Massague J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009, 9:274-284
34. Kaariainen E, Nummela P, Soikkeli J, Yin M, Lukk M, Jahkola T, Virolainen S, Ora A, Ukkonen E, Saksela O, Holtta E: Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion. J Pathol 2006, 210:181-191
35. Moretti FA, Chauhan AK, Iaconcig A, Porro F, Baralle FE, Muro AF: A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 2007, 282:28057-28062 (Pubitemid 47529518)
36. Astrof S, Hynes RO: Fibronectins in vascular morphogenesis. Angio-genesis 2009, 12:165-175
37. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, Germain RN: Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006, 25:989-1001 (Pubitemid 44914055)
38. Wierzbicka-Patynowski I, Schwarzbauer JE: The ins and outs of fibronectin matrix assembly. J Cell Sci 2003, 116:3269-3276 (Pubitemid 37038975)
39. Ingham KC, Brew SA, Erickson HP: Localization of a cryptic binding site for tenascin on fibronectin. J Biol Chem 2004, 279:28132-28135
40. Kadler KE, Hill A, Canty-Laird EG: Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 2008, 20:495-501
41. Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, Moreno-Rodriguez R, Trusk T, Potts JD, Goodwin RL, Davis J, Hoffman S, Wen X, Sugi Y, Kern CB, Mjaatvedt CH, Turner DK, Oka T, Conway SJ, Molkentin JD, Forgacs G, Markwald RR: Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007, 101:695-711
42. Pankov R, Yamada KM: Fibronectin at a glance. J Cell Sci 2002, 115:3861-3863
43. Hynes R: Molecular biology of fibronectin. Annu Rev Cell Biol 1985, 1:67-90
44. Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T: Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 2007, 22:1167-1174
45. Clout NJ, Tisi D, Hohenester E: Novel fold revealed by the structure of a FAS1 domain pair from the insect cell adhesion molecule fasciclin I. Structure 2003, 11:197-203
46. Katsuragi N, Morishita R, Nakamura N, Ochiai T, Taniyama Y, Hasegawa Y, Kawashima K, Kaneda Y, Ogihara T, Sugimura K: Periostin as a novel factor responsible for ventricular dilation. Circulation 2004, 110:1806-1813 (Pubitemid 39299222)
47. Wight TN: Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002, 14:617-623
48. Kim CJ, Yoshioka N, Tambe Y, Kushima R, Okada Y, Inoue H: Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int J Cancer 2005, 117:51-58
49. Yoshioka N, Fuji S, Shimakage M, Kodama K, Hakura A, Yutsudo M, Inoue H, Nojima H: Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. Exp Cell Res 2002, 279:91-99
50. Castronovo V, Waltregny D, Kischel P, Roesli C, Elia G, Rybak JN, Neri D: A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics 2006, 5:2083-2091
51. Tai IT, Dai M, Chen LB: Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis 2005, 26:908-915
52. Wilde J, Yokozeki M, Terai K, Kudo A, Moriyama K: The divergent expression of periostin mRNA in the periodontal ligament during experimental tooth movement. Cell Tissue Res 2003, 312:345-351
53. Javelaud D, Alexaki VI, Mauviel A: Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res 2008, 21:123-132
54. Berking C, Takemoto R, Schaider H, Showe L, Satyamoorthy K, Robbins P, Herlyn M: Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Res 2001, 61:8306-8316
55. Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A: Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer 2007, 6:80
56. Liotta LA, Kohn EC: The microenvironment of the tumour-host interface. Nature 2001, 411:375-379
57. Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401
58. Egeblad M, Littlepage LE, Werb Z: The fibroblastic coconspirator in cancer progression. Cold Spring Harb Symp Quant Biol 2005, 70:383-388
59. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E: Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007, 9:1392-1400
60. Sottile J, Hocking DC, Langenbach KJ: Fibronectin polymerization stimulates cell growth by RGD-dependent and -independent mechanisms. J Cell Sci 2000, 113 Pt 23:4287-4299
61. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF: Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999, 5:1041-1056
62. Khan ZA, Chan BM, Uniyal S, Barbin YP, Farhangkhoee H, Chen S, Chakrabarti S: EDB fibronectin and angiogenesis - a novel mechanistic pathway. Angiogenesis 2005, 8:183-196
63. Zhou X, Rowe RG, Hiraoka N, George JP, Wirtz D, Mosher DF, Virtanen I, Chernousov MA, Weiss SJ: Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev 2008, 22:1231-1243
64. Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP: Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 2005, 25:77-83
65. Siriwardena BS, Kudo Y, Ogawa I, Kitagawa M, Kitajima S, Hatano H, Tilakaratne WM, Miyauchi M, Takata T: Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 2006, 95:1396-1403
66. Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang T, Gishizky ML, Marks JR, Wang XF: Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004, 24:3992-4003
67. Rybak JN, Roesli C, Kaspar M, Villa A, Neri D: The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 2007, 67:10948-10957
68. Noma K, Smalley KS, Lioni M, Naomoto Y, Tanaka N, El-Deiry W, King AJ, Nakagawa H, Herlyn M: The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 2008, 134:1981-1993